Growth pattern in children with X-linked hypophosphatemia treated with burosumab and growth hormone

BACKGROUND: X-linked hypophosphatemia (XLH) is characterized by increased serum concentrations of fibroblast growth factor 23 (FGF23), hypophosphatemia and insufficient endogenous synthesis of calcitriol. Beside rickets, odonto- and osteomalacia, disproportionate short stature is seen in most affect...

Descripción completa

Detalles Bibliográficos
Autores principales: Ertl, Diana-Alexandra, Le Lorier, Justin, Gleiss, Andreas, Trabado, Séverine, Bensignor, Candace, Audrain, Christelle, Zhukouskaya, Volha, Coutant, Régis, Berkenou, Jugurtha, Rothenbuhler, Anya, Haeusler, Gabriele, Linglart, Agnès
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652849/
https://www.ncbi.nlm.nih.gov/pubmed/36371259
http://dx.doi.org/10.1186/s13023-022-02562-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652849/
https://www.ncbi.nlm.nih.gov/pubmed/36371259
http://dx.doi.org/10.1186/s13023-022-02562-9

Ejemplares similares